Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1967 Jun 10;2(5553):679–681. doi: 10.1136/bmj.2.5553.679

Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

J Houseley, J J Oppenheim
PMCID: PMC1842300  PMID: 6024528

Full text

PDF
681

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ADNER M. M., SHERMAN J. D., ISE C., SCHWAB R. S., DAMESHEK W. AN IMMUNOLOGIC SURVEY OF FORTY-EIGHT PATIENTS WITH MYASTHENIA GRAVIS. N Engl J Med. 1964 Dec 24;271:1327–1333. doi: 10.1056/NEJM196412242712601. [DOI] [PubMed] [Google Scholar]
  2. DUTTON R. W., EADY J. D. AN IN VITRO SYSTEM FOR THE STUDY OF THE MECHANISM OF ANTIGENIC STIMULATION IN THE SECONDARY RESPONSE. Immunology. 1964 Jan;7:40–53. [PMC free article] [PubMed] [Google Scholar]
  3. HIRSCHHORN K., SCHREIBMAN R. R., BACH F. H., SILTZBACH L. E. IN-VITRO STUDIES OF LYMPHOCYTES FROM PATIENTS WITH SARCOIDOSIS AND LYMPHOPROLIFERATIVE DISEASES. Lancet. 1964 Oct 17;2(7364):842–843. doi: 10.1016/s0140-6736(64)90691-9. [DOI] [PubMed] [Google Scholar]
  4. KORNFELD P., SIEGAL S., WEINER L. B., OSSERMAN K. E. STUDIES IN MYASTHENIA GRAVIS. IMMUNOLOGIC RESPONSE IN THYMECTOMIZED AND NONTHYMECTOMIZED PATIENTS. Ann Intern Med. 1965 Sep;63:416–428. doi: 10.7326/0003-4819-63-3-416. [DOI] [PubMed] [Google Scholar]
  5. NASTUK W. L., PLESCIA O. J., OSSERMAN K. E. Changes in serum complement activity in patients with myasthenia gravis. Proc Soc Exp Biol Med. 1960 Oct;105:177–184. doi: 10.3181/00379727-105-26050. [DOI] [PubMed] [Google Scholar]
  6. Oppenheim J. J., Barlow M., Waldmann T. A., Block J. B. Impaired in vitro lymphocyte transformation in patients with ataxia-telangiectasis. Br Med J. 1966 Aug 6;2(5509):330–333. doi: 10.1136/bmj.2.5509.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Osserman K. E., Weiner L. B. Studies in myasthenia gravis: immunofluorescent tagging of muscle striation with antibody from serums of 256 myasthenic patients. Ann N Y Acad Sci. 1965 Jun 30;124(2):730–743. doi: 10.1111/j.1749-6632.1965.tb18998.x. [DOI] [PubMed] [Google Scholar]
  8. STURGILL B. C., CARPENTER R. R., STRAUSS A. J., GOODMAN H. C. ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS WHICH REACT WITH THERMALLY DENATURED DNA-COATED BENTONITE. Proc Soc Exp Biol Med. 1964 Jan;115:246–251. doi: 10.3181/00379727-115-28882. [DOI] [PubMed] [Google Scholar]
  9. Strauss A. J., van der Geld H. W., Kemp P. G., Jr, Exum E. D., Goodman H. C. Immunological concomitants of myasthenia gravis. Ann N Y Acad Sci. 1965 Jun 30;124(2):744–766. doi: 10.1111/j.1749-6632.1965.tb18999.x. [DOI] [PubMed] [Google Scholar]
  10. WHITE R. G., MARSHALL A. H. The autoimmune response in myasthenia gravis. Lancet. 1962 Jul 21;2(7247):120–123. doi: 10.1016/s0140-6736(62)90005-3. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES